Mechanistic insights into Nrf2-driven pathogenesis and therapeutic targeting in spinal cord injury

Spinal cord injury (SCI) is a traumatic disease of the central nervous system that can result in significant tissue damage and neurological dysfunction. The pathophysiological process of SCI encompasses both primary and secondary injuries, involving various pathological mechanisms such as oxidative...

Full description

Saved in:
Bibliographic Details
Main Authors: Tao Xie, Jiyu Xu, Xinyu Liu, Yaquan Yu, Yang Lu, Tao Wang, Feng Gao, Hui Yuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1574834/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839634511555461120
author Tao Xie
Tao Xie
Jiyu Xu
Xinyu Liu
Yaquan Yu
Yang Lu
Tao Wang
Feng Gao
Hui Yuan
Hui Yuan
author_facet Tao Xie
Tao Xie
Jiyu Xu
Xinyu Liu
Yaquan Yu
Yang Lu
Tao Wang
Feng Gao
Hui Yuan
Hui Yuan
author_sort Tao Xie
collection DOAJ
description Spinal cord injury (SCI) is a traumatic disease of the central nervous system that can result in significant tissue damage and neurological dysfunction. The pathophysiological process of SCI encompasses both primary and secondary injuries, involving various pathological mechanisms such as oxidative stress, inflammation, autophagy, ferroptosis, and mitochondrial dysfunction. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a neuroprotective transcription factor intricately linked to these pathological processes. Upon exposure to external stimuli, Nrf2 undergoes increased nuclear transcription, regulating the expression of various antioxidant genes and directly modulating genes associated with the aforementioned pathological mechanisms to counteract the resultant alterations. Substantial evidence suggests that Nrf2 may be a potential therapeutic target for SCI. Activation of the Nrf2-related signaling pathway effectively inhibits neuronal death following SCI and promotes the recovery of multiple neurological functions. This review provides an overview of recent research on SCI, examines the physiological roles and mechanisms of Nrf2 in SCI, and explores therapeutic strategies targeting this signaling pathway, including non-coding RNAs, natural and synthetic compounds, and other treatments for SCI.
format Article
id doaj-art-1e9b637a21b8457aad1666c1e17b6e09
institution Matheson Library
issn 1664-3224
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-1e9b637a21b8457aad1666c1e17b6e092025-07-10T05:30:00ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-07-011610.3389/fimmu.2025.15748341574834Mechanistic insights into Nrf2-driven pathogenesis and therapeutic targeting in spinal cord injuryTao Xie0Tao Xie1Jiyu Xu2Xinyu Liu3Yaquan Yu4Yang Lu5Tao Wang6Feng Gao7Hui Yuan8Hui Yuan9School of Basic Medical Sciences, Mudanjiang Medical University, Mudanjiang, ChinaSchool of Clinical Medicine, Jiamusi University, Jiamusi, ChinaSchool of Medical Imaging, Mudanjiang Medical University, Mudanjiang, ChinaSchool of Basic Medical Sciences, Mudanjiang Medical University, Mudanjiang, ChinaDepartment of Gastroenterology, Yang Zhou Hong Quan Hospital, Yang Zhou, ChinaDepartment of Anesthesiology, Mudanjiang Traditional Chinese Medicine Hospital, Mudanjiang, ChinaDepartment of Anesthesiology, Mudanjiang Traditional Chinese Medicine Hospital, Mudanjiang, ChinaDepartment of Anesthesiology, Mudanjiang Traditional Chinese Medicine Hospital, Mudanjiang, ChinaSchool of Basic Medical Sciences, Mudanjiang Medical University, Mudanjiang, ChinaSchool of Stomatology, Mudanjiang Medical University, Mudanjiang, ChinaSpinal cord injury (SCI) is a traumatic disease of the central nervous system that can result in significant tissue damage and neurological dysfunction. The pathophysiological process of SCI encompasses both primary and secondary injuries, involving various pathological mechanisms such as oxidative stress, inflammation, autophagy, ferroptosis, and mitochondrial dysfunction. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a neuroprotective transcription factor intricately linked to these pathological processes. Upon exposure to external stimuli, Nrf2 undergoes increased nuclear transcription, regulating the expression of various antioxidant genes and directly modulating genes associated with the aforementioned pathological mechanisms to counteract the resultant alterations. Substantial evidence suggests that Nrf2 may be a potential therapeutic target for SCI. Activation of the Nrf2-related signaling pathway effectively inhibits neuronal death following SCI and promotes the recovery of multiple neurological functions. This review provides an overview of recent research on SCI, examines the physiological roles and mechanisms of Nrf2 in SCI, and explores therapeutic strategies targeting this signaling pathway, including non-coding RNAs, natural and synthetic compounds, and other treatments for SCI.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1574834/fullspinal cord injuryNrf2oxidative stressinflammationferroptosis
spellingShingle Tao Xie
Tao Xie
Jiyu Xu
Xinyu Liu
Yaquan Yu
Yang Lu
Tao Wang
Feng Gao
Hui Yuan
Hui Yuan
Mechanistic insights into Nrf2-driven pathogenesis and therapeutic targeting in spinal cord injury
Frontiers in Immunology
spinal cord injury
Nrf2
oxidative stress
inflammation
ferroptosis
title Mechanistic insights into Nrf2-driven pathogenesis and therapeutic targeting in spinal cord injury
title_full Mechanistic insights into Nrf2-driven pathogenesis and therapeutic targeting in spinal cord injury
title_fullStr Mechanistic insights into Nrf2-driven pathogenesis and therapeutic targeting in spinal cord injury
title_full_unstemmed Mechanistic insights into Nrf2-driven pathogenesis and therapeutic targeting in spinal cord injury
title_short Mechanistic insights into Nrf2-driven pathogenesis and therapeutic targeting in spinal cord injury
title_sort mechanistic insights into nrf2 driven pathogenesis and therapeutic targeting in spinal cord injury
topic spinal cord injury
Nrf2
oxidative stress
inflammation
ferroptosis
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1574834/full
work_keys_str_mv AT taoxie mechanisticinsightsintonrf2drivenpathogenesisandtherapeutictargetinginspinalcordinjury
AT taoxie mechanisticinsightsintonrf2drivenpathogenesisandtherapeutictargetinginspinalcordinjury
AT jiyuxu mechanisticinsightsintonrf2drivenpathogenesisandtherapeutictargetinginspinalcordinjury
AT xinyuliu mechanisticinsightsintonrf2drivenpathogenesisandtherapeutictargetinginspinalcordinjury
AT yaquanyu mechanisticinsightsintonrf2drivenpathogenesisandtherapeutictargetinginspinalcordinjury
AT yanglu mechanisticinsightsintonrf2drivenpathogenesisandtherapeutictargetinginspinalcordinjury
AT taowang mechanisticinsightsintonrf2drivenpathogenesisandtherapeutictargetinginspinalcordinjury
AT fenggao mechanisticinsightsintonrf2drivenpathogenesisandtherapeutictargetinginspinalcordinjury
AT huiyuan mechanisticinsightsintonrf2drivenpathogenesisandtherapeutictargetinginspinalcordinjury
AT huiyuan mechanisticinsightsintonrf2drivenpathogenesisandtherapeutictargetinginspinalcordinjury